Bladder Cancer

Impact of salvage cytotoxic chemotherapy on prognosis in patients with recurrence after radical cystectomy: a multi-institutional retrospective study. May 17, 2022

Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoring. May 17, 2022

Activation of the chemokine receptor 3 pathway leads to a better response to immune checkpoint inhibitors in patients with metastatic urothelial carcinoma. May 16, 2022

Socio-economic burden of disease: Survivorship costs for bladder cancer. May 16, 2022

How do endoscopic bladder tumor resection techniques affect pathology practice? EAU Section of Uro-Technology (ESUT) and Uropathology (ESUP) survey. May 16, 2022

Adjuvant Immunotherapy in Patients with High-Risk Muscle-Invasive Urothelial Carcinoma: The Potential Impact of Informative Censoring May 13, 2022

Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab. May 13, 2022

[How has the Paris System contributed to urine cytology? Evaluating the contribution of the Paris System to urine cytology. A comparative study of the Paris System and the Papanicolaou method in a tertiary centre]. May 13, 2022

What is the impact of dynamic contrast-enhancement sequence in the Vesical Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis. May 13, 2022

National Implementation of Simulator Training Improves Transurethral Resection of Bladder Tumours in Patients. May 12, 2022

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice. May 12, 2022

Learning Curve Analysis for Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section Scientific Working Group. May 11, 2022

Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study. May 11, 2022

Prediction of the Immune Phenotypes of Bladder Cancer Patients for Precision Oncology. May 10, 2022

Quality-of-Life Outcomes in Female Patients With Ileal Conduit or Orthotopic Neobladder Urinary Diversion: 6-Month Results of a Multicenter Prospective Study. May 10, 2022

Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity. May 9, 2022

Clinical outcomes and patterns of population-based management of urachal carcinoma of the bladder: An analysis of the National Cancer Database. May 9, 2022

Identification of Potential Biomarkers for Progression and Prognosis of Bladder Cancer by Comprehensive Bioinformatics Analysis. May 6, 2022

BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer. May 6, 2022

ANLN Serves as an Oncogene in Bladder Urothelial Carcinoma via Activating JNK Signaling Pathway. May 5, 2022

Page 1 of 427

email news signup